Sarcoidosis complicating treatment with natalizumab for Crohn's disease
<p style="text-align:justify;"> Natalizumab is a humanised monoclonal antibody targeting the lymphocyte adhesion molecule a4 integrin, with proven efficacy in multiple sclerosis (MS) and Crohn's disease (CD). The development of sarcoidosis with extrapulmonary involvement is rep...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Published: |
BMJ Publishing Group
2011
|